U.S. flag

An official website of the United States government

NM_001080414.4(CCDC88C):c.1702C>T (p.Arg568Ter) AND not provided

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Feb 25, 2024
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003721104.4

Allele description [Variation Report for NM_001080414.4(CCDC88C):c.1702C>T (p.Arg568Ter)]

NM_001080414.4(CCDC88C):c.1702C>T (p.Arg568Ter)

Gene:
CCDC88C:coiled-coil and HOOK domain protein 88C [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
14q32.11
Genomic location:
Preferred name:
NM_001080414.4(CCDC88C):c.1702C>T (p.Arg568Ter)
HGVS:
  • NC_000014.9:g.91314114G>A
  • NG_033118.2:g.108731C>T
  • NM_001080414.4:c.1702C>TMANE SELECT
  • NP_001073883.2:p.Arg568Ter
  • NC_000014.8:g.91780458G>A
  • NR_189158.1:n.1832C>T
  • NR_189159.1:n.1832C>T
Protein change:
R568*
Links:
dbSNP: rs777488098
Molecular consequence:
  • NM_001080414.4:c.1702C>T - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004502123Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Feb 25, 2024)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Two novel CCDC88C mutations confirm the role of DAPLE in autosomal recessive congenital hydrocephalus.

Drielsma A, Jalas C, Simonis N, Désir J, Simanovsky N, Pirson I, Elpeleg O, Abramowicz M, Edvardson S.

J Med Genet. 2012 Nov;49(11):708-12. doi: 10.1136/jmedgenet-2012-101190. Epub 2012 Oct 5.

PubMed [citation]
PMID:
23042809

Surprisingly good outcome in antenatal diagnosis of severe hydrocephalus related to CCDC88C deficiency.

Wallis M, Baumer A, Smaili W, Jaouad IC, Sefiani A, Jacobson E, Bowyer L, Mowat D, Rauch A.

Eur J Med Genet. 2018 Apr;61(4):189-196. doi: 10.1016/j.ejmg.2017.12.002. Epub 2017 Dec 7.

PubMed [citation]
PMID:
29225145
See all PubMed Citations (3)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV004502123.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

This sequence change creates a premature translational stop signal (p.Arg568*) in the CCDC88C gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CCDC88C are known to be pathogenic (PMID: 23042809, 29225145). This variant is present in population databases (rs777488098, gnomAD 0.006%). This premature translational stop signal has been observed in individual(s) with hydrocephalus (PMID: 29225145). For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 10, 2026

Modify your search Search (all fields optional) Clear all
Advanced Search